DA

Dannielle Appelhans

President and Chief Executive Officer

Cour Pharmaceuticals Development Co., Inc.

Chicago, Illinois


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Cour Pharmaceuticals Development Co., Inc.
Industry
pharmaceuticals
Employees
77.0
Seniority
C suite
Annual Revenue
4300000.0
Total Funding
135169251.0
Latest Funding
Series A

Technologies

Outlook Microsoft Office 365 Google Cloud Hosting Nginx Shutterstock Google Font API WordPress.org Mobile Friendly Google Tag Manager Circle Remote

Keywords

pharmaceuticals immunology nanomedicine immune tolerance inflammation nanotechnology pharmaceutical manufacturing immune reprogramming antigen-specific tolerance immune-mediated disease biodegradable nanoparticles clinical trials autoimmune therapies cnp-103 type 1 diabetes treatment cnp-104 primary biliary cholangitis cnp-106 myasthenia gravis nanoparticle technology therapeutic efficacy fda clearance therapeutic advancement cnp-101 celiac disease immune function preservation preclinical studies targeted delivery immune modulation monocyte targeting adaptive immune response t regulatory cells genetic autoimmune disorders gliadin encapsulation immunotherapy clinical efficacy immunosuppressive therapies disease-specific antigens t-cell deletion pharmaceutical innovation immune deficiency therapeutic collaboration licensed programs immune response management disease progression medical partnerships research collaboration dynamic immune therapy novel drug development cancer prevention nutritional deficiencies vaccine development immune health chronic illness management medical health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans